Inflammatory Diseases

DIA Annual Meeting 2021

DIA 2021 will explore the potential of RNA based therapeutics

17-Jun-2021 By Jane Byrne

In recent years, it has become clear that RNA molecules are an emerging as a class of therapeutics of relevance to multiple diseases, most recently including COVID-19 vaccines.

Spotlight

(adventtr/iStock via Getty Images Plus)

Gates Foundation, Exscientia enter $70m agreement to develop COVID-19 treatments

(Meletios Verras/iStock via Getty Images Plus)

Doctors believe in immunotherapy’s cancer-fighting potential: BMS survey

(dem10/iStock via Getty Images Plus)

Global Genes kicks off rare-disease patient engagement effort

(Adam Gault/iStock via Getty Images Plus)

NIH offers $185m to further understanding of the human genome

(AJ_Watt/iStock via Getty Images Plus)

Pfizer, Myovant announce sNDA review for endometriosis treatment

Follow us

Products

View more

Webinars

Upcoming supplier webinars

12 Oct 2021 Tue Maximize lab productivity and quality by embracing expected ICH Q14 Enhanced Method Development Guidelines and AQbD approaches

On-demand webinars

Featured Suppliers

All suppliers

Ajinomoto Bio-Pharma Services

Baxter BioPharma Solutions

BioContinuum™ Platform - MilliporeSigma

BioReliance® End-to-End Solutions

Covance Patient Safety

Frontage Laboratories

Laurus Labs Ltd.

Piramal Pharma Solutions

PRA Health Sciences

Precision for Medicine

Softigel by Procaps

Vetter Pharma International GmbH